Unlock instant, AI-driven research and patent intelligence for your innovation.

Construction of nanoreactor encapsulated with arginine deiminase

A technology of arginine deiminase and nano-reactor, which is applied in the field of construction of ADI-loaded nano-reactor, can solve the problems of affecting urease activity, activity reduction, short half-life, etc.

Inactive Publication Date: 2018-05-08
WUHAN UNIV OF TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Chinese patent document 201310112299.5 discloses a urease nanoreactor using carboxymethyl chitosan as a carrier material, but the encapsulation process of urease is accompanied by ultrasound, which will affect the activity of urease; There is no report on the construction of ADI nanoreactor based on chitosan as carrier material
[0007] The main technical problems to be solved by the present invention are: (1) the half-life of ADI in the body is shorter, only 4h in the mouse body
(3) The modification of PEG can prolong its blood circulation life and reduce its immunogenicity, but its activity is also significantly reduced

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction of nanoreactor encapsulated with arginine deiminase
  • Construction of nanoreactor encapsulated with arginine deiminase
  • Construction of nanoreactor encapsulated with arginine deiminase

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] According to the molar ratio of the structural unit of CMCNa (DD=95.2%, DS=1.02) and azide benzaldehyde (Az) is 1:1, the Az dissolved in ethanol is added dropwise in the CMCNa aqueous solution, stirred at room temperature for 8 Hour, obtain Az-CMCNa solution. The crude product was precipitated by adding 95% ethanol to the solution, washed three times with 95% ethanol (v / v), and finally dried under vacuum at 45° C. to obtain Az-CMCNa.

[0041] Use a probe-type sonicator to ultrasonically treat 0.4% (w / w) Az-CMCNa aqueous solution for 3 minutes to obtain a micellar dispersion, then add ADI to the micellar dispersion to a concentration of 30ug / ml, and then drop while stirring Dilute hydrochloric acid solution was added until the molar ratio of added hydrochloric acid to ionized carboxyl groups in Az-CMCNa was 1:1, at which point the micelles transformed into ADI-containing nanocapsules. The capsule solution was exposed to 250nm UV light for 20 seconds to induce in-situ cr...

Embodiment 2

[0043] According to the molar ratio of the structural unit of CMCNa (DD=90.0%, DS=0.62) and azidobenzaldehyde (Az) is 1:2, the Az dissolved in ethanol is added dropwise in the CMCNa aqueous solution, stirred at room temperature for 8 Hour, obtain Az-CMCNa solution. The crude product was precipitated by adding 95% ethanol to the solution, washed three times with 95% ethanol (v / v), and finally dried under vacuum at 45° C. to obtain Az-CMCNa. Use a probe-type sonicator to sonicate 0.2% (w / w) Az-CMCNa aqueous solution for 3 minutes to obtain a micellar dispersion, then add ADI to the solution to a concentration of 45ug / ml, and then add dilute hydrochloric acid dropwise while stirring solution until the molar ratio of added hydrochloric acid to ionized carboxyl groups in Az-CMCNa was 1:1, at which point the micelles transformed into ADI-containing nanocapsules. The capsule solution was exposed to 254 nm UV light for 30 seconds to induce in situ cross-linking of the AZ groups in th...

Embodiment 3

[0045] According to the molar ratio of the structural unit of CMCNa (DD=93.0%, DS=0.87) and azide benzaldehyde (Az) is 1:0.5, Az dissolved in 95% ethanol is added dropwise in CMCNa aqueous solution, at room temperature After stirring for 8 hours, Az-CMCNa solution was obtained. The crude product was precipitated by adding 95% ethanol to the solution, washed three times with 95% ethanol (v / v), and finally dried under vacuum at 45° C. to obtain Az-CMCNa. Use a probe-type sonicator to sonicate 0.1% (w / w) Az-CMCNa aqueous solution for 3 minutes to obtain a micellar dispersion, then add ADI to the solution to a concentration of 65ug / ml, and then add dilute hydrochloric acid dropwise while stirring solution until the molar ratio of added hydrochloric acid to ionized carboxyl groups in Az-CMCNa was 1:1, at which point the micelles transformed into ADI-containing nanocapsules. The capsule solution was exposed to 260 nm UV light for 20 seconds to induce in situ cross-linking of the AZ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention relates to construction of a nanoreactor encapsulated with arginine deiminase, and the nanoreactor comprises effective ingredients: photo-crosslinking amphiphilic polymers and the arginine deiminase. The nanoreactor encapsulated with the arginine deiminase is prepared according to the following method: converting a photo-crosslinkable carboxymethyl chitosan sodium salt micelle into ananocapsule through pH induction, so that the arginine deiminase is encapsulated under the mild condition; through ultraviolet radiation crosslinking, fast locking a structure of the nanocapsule, soas to obtain the nanoreactor encapsulated with the arginine deiminase, which is stable and high in activity. The prepared nanoreactor encapsulated with the arginine deiminase integrates self-assemblyand the encapsulated arginine deiminase and is simple in preparation method; in addition, the nanoreactor is high in activity for arginine metabolism, so that the nanoreactor has potential applicationvalue in the fields of treatment of cancer, and the like.

Description

technical field [0001] The invention relates to an enzyme nanoreactor, in particular to the construction of an ADI nanoreactor. Background technique [0002] Recently, approaches to treat certain malignancies based on tumor metabolism have come into focus. The use of metabolic enzymes to degrade or deprive tumors of essential amino acids for survival, so-called amino acid deprivation therapy, has been used in the treatment of acute lymphoblastic leukemia. Arginine is a non-essential amino acid in the adult body, which is derived from the synthesis of citrulline through the conversion catalyzed by two key enzymes. These two enzymes are argininosuccinate synthetase (argininosuccinate synthetase1, ASS1) and argininosuccinate lyase (argininosuccinate-ate lyase, ASL), and ASS1 is a key rate-limiting enzyme in the synthesis process. Due to the lack of ASS1, some malignant cells must use exogenous arginine to meet their growth and proliferation needs. [0003] By intravenously i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/50A61K9/127A61K47/36A61P35/00
CPCA61K9/0009A61K9/1273A61K9/1277A61K38/50A61K47/36C12Y305/03006
Inventor 殷以华万燕鸣代悦潘茜郑丽敏
Owner WUHAN UNIV OF TECH